SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Life Sciences planning to raise Rs 750 crore via NCDs

25 Jun 2018 Evaluate

Jubilant Life Sciences is planning to raise funds up to an amount of Rs 750 crore by issuance of Non-Convertible Debentures (NCDs). The meeting of the Board of Directors of the company is scheduled to be held on June 27, 2018, to consider the same.

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.


Jubilant Pharmova Share Price

913.15 1.55 (0.17%)
20-Apr-2026 10:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1236.30
Cipla 1237.70
Zydus Lifesciences 943.20
Lupin 2331.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×